Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 52
Filter
3.
Exp Neurol ; 322: 113035, 2019 12.
Article in English | MEDLINE | ID: mdl-31446080

ABSTRACT

The cortical reorganization after spinal cord injury (SCI) involves a series of physiological changes that drive the expansion of the intact cortical area to the deafferented cortical area. These changes have always been studied under a stimulus-response paradigm, which demonstrates that the deafferented cortex becomes more responsive to stimulation of body regions above the level of the lesion. However, less is known about how permanent large-scale deafferentation affects spontaneous activity in the somatosensory cortex, an important physiological feature related to the processing of peripheral inputs and perception. Here we studied the spontaneous activity at two sites of the somatosensory cortex, corresponding to forepaw and hindpaw, and at three different time points after SCI: acute SCI, one week post-SCI and chronic SCI (1-3 months after injury). Electrophysiological recordings from anesthetized rats were obtained in conditions of slow-wave activity in order to compare features of the neural populations in periods of cortical up-states. Our data demonstrate that acute SCI reduces the excitability of cortical neurons during up-states in both the forepaw and the hindpaw cortex. One week after SCI, the properties of cortical neurons were similar to those under control conditions, indicating a homeostatic plasticity. Finally, chronic SCI increased neural activity during up-states, while reduced up-state frequency in the cortex. We conclude that SCI induces different homeostatic changes in cortical slow-wave depending on the time after lesion. This temporal evolution of spontaneous activity could help better understand the cortical plasticity associated with acute or chronic SCI.


Subject(s)
Homeostasis/physiology , Neuronal Plasticity/physiology , Somatosensory Cortex/physiopathology , Spinal Cord Injuries/physiopathology , Animals , Male , Rats , Rats, Wistar
4.
Arch. Soc. Esp. Oftalmol ; 93(10): 497-502, oct. 2018. tab, ilus
Article in Spanish | IBECS | ID: ibc-175125

ABSTRACT

CASOS CLÍNICOS: Presentamos 10 casos de queratitis por Acanthamoeba tratados en nuestro hospital entre 2008 y 2017. Todos eran portadores de lentes de contacto. Como tratamiento todos recibieron una biguanida junto a una diamidina. En 3 casos la infección no superaba el estroma superficial, respondiendo al tratamiento tópico. En 7 alcanzaba el estroma profundo, precisando 6 de ellos una queratoplastia penetrante, 3 «en caliente» por riesgo de perforación o extensión ocular. La agudeza visual mejoró en todos los casos. CONCLUSIÓN: La profundidad de la infección al diagnóstico aparece como el principal factor de riesgo para necesitar una queratoplastia penetrante


CLINICAL CASES: Cases are presented of 10 patients with Acanthamoeba keratitis treated between 2008 and 2017. All were contact lens wearers. All of them received treatment with a biguanide combined with a diamidine. In 3 cases the infestation did not exceed the superficial stroma, responding to topical treatment. In 7, the infection reached the deep stroma, with 6 of these cases requiring penetrating keratoplasty (PKP), 3 of them therapeutic PKP because of perforation risk or ocular spreading. The visual acuity improved in all the cases. CONCLUSION: The infestation depth at the time of diagnosis appears to be the main risk factor for requiring a PKP


Subject(s)
Humans , Male , Female , Child , Adolescent , Young Adult , Adult , Middle Aged , Acanthamoeba Keratitis/diagnosis , Acanthamoeba Keratitis/drug therapy , Biguanides/therapeutic use , Diamines/therapeutic use , Eye Infections/diagnosis , Early Diagnosis , Biopsy , Acanthamoeba Keratitis/parasitology , Visual Acuity , Contact Lenses/parasitology , Eye Infections/drug therapy , Eye Infections/parasitology
5.
Arch Soc Esp Oftalmol (Engl Ed) ; 93(10): 497-502, 2018 Oct.
Article in English, Spanish | MEDLINE | ID: mdl-29885816

ABSTRACT

CLINICAL CASES: Cases are presented of 10 patients with Acanthamoeba keratitis treated between 2008 and 2017. All were contact lens wearers. All of them received treatment with a biguanide combined with a diamidine. In 3 cases the infestation did not exceed the superficial stroma, responding to topical treatment. In 7, the infection reached the deep stroma, with 6 of these cases requiring penetrating keratoplasty (PKP), 3 of them therapeutic PKP because of perforation risk or ocular spreading. The visual acuity improved in all the cases. CONCLUSION: The infestation depth at the time of diagnosis appears to be the main risk factor for requiring a PKP.


Subject(s)
Acanthamoeba Keratitis , Acanthamoeba Keratitis/diagnosis , Acanthamoeba Keratitis/parasitology , Acanthamoeba Keratitis/pathology , Acanthamoeba Keratitis/therapy , Adolescent , Amebicides/therapeutic use , Biguanides/therapeutic use , Child , Conjunctivitis/diagnosis , Contact Lenses , Corneal Stroma/parasitology , Corneal Stroma/pathology , Diagnostic Errors , Female , Humans , Keratitis/diagnosis , Keratoplasty, Penetrating , Male , Microscopy, Confocal , Middle Aged , Pentamidine/therapeutic use , Retrospective Studies , Slit Lamp , Treatment Outcome , Young Adult
6.
Clin Exp Dermatol ; 43(8): 876-882, 2018 Dec.
Article in English | MEDLINE | ID: mdl-29756221

ABSTRACT

BACKGROUND: Cutaneous squamous cell carcinoma (cSCC) represents the most common form of skin cancer after basal cell carcinoma, and can be both locally invasive and metastatic to distant sites. Growth rate (GR) has been poorly evaluated in cSCC, despite clinical evidence suggesting that GR is an important risk factor in cSCC. AIM: To analyse the influence of GR in cSCC prognosis. METHODS: We retrospectively evaluated GR in a series of 90 cSCCs and tried to correlate GR with prognosis in cSCC. RESULTS: We demonstrated that tumours with a GR of > 4 mm/month exhibit a higher risk of nodal progression and a shorter progression time to lymph node metastasis in cSCC than those with GR of < 4 mm/month. As expected, GR correlated with tumour proliferation, as determined by Ki-67 expression. CONCLUSIONS: We consider a GR of 4 mm/month as the cutoff point that distinguishes between rapid- and slow-progressing tumours and, more importantly, to identify a subset of high-risk cSCCs.


Subject(s)
Carcinoma, Squamous Cell/pathology , Disease Progression , Skin Neoplasms/pathology , Aged , Aged, 80 and over , Antigens, Surface/metabolism , Female , Humans , Logistic Models , Lymphatic Metastasis , Male , Prognosis , Retrospective Studies , Risk Factors
7.
Actas dermo-sifiliogr. (Ed. impr.) ; 109(3): 207-217, abr. 2018. ilus, graf, tab
Article in Spanish | IBECS | ID: ibc-172826

ABSTRACT

El síndrome de Gorlin es una enfermedad infrecuente de herencia autosómica dominante producida por mutaciones en genes de la vía de señalización Sonic Hedgehog, entre los que destaca PTCH1. Se caracteriza por el desarrollo de múltiples carcinomas basocelulares en edades tempranas, que pueden ir asociados a otras manifestaciones cutáneas como pits palmoplantares, o a manifestaciones extracutáneas, entre las que destacan los queratoquistes odontogénicos y el meduloblastoma. El papel del dermatólogo es importante en la sospecha de este síndrome, pero suele ser necesario un equipo multidisciplinar en el diagnóstico, seguimiento y en el tratamiento de estos pacientes. El tratamiento dermatológico puede ser complicado debido al alto número de carcinomas basocelulares y a su extensión. En los últimos años se han desarrollado nuevos fármacos que inhiben la vía Sonic Hedgehog y parecen prometedores para estos pacientes, aunque su eficacia está limitada por los efectos secundarios y la creación de resistencias


Gorlin syndrome is a rare autosomal dominant disease caused by mutations in the sonic hedgehog signaling pathway. Of particular importance is the PTCH1 gene. The disease is characterized by the development of multiple basal cell carcinomas at young ages. These tumors may present with other skin manifestations such as palmoplantar pits and with extracutaneous manifestations such as odontogenic keratocysts and medulloblastoma. Although the dermatologist may be key for recognizing clinical suspicion of the syndrome, a multidisciplinary team is usually necessary for diagnosis, treatment, and follow-up. Skin treatment may be complicated due to the large number of basal cell carcinomas and the extent of involvement. In recent years, new drugs that inhibit targets in the sonic hedgehog pathway have been developed. Although these agents appear promising options for patients with Gorlin syndrome, their efficacy is limited by adverse effects and the development of resistance


Subject(s)
Humans , Basal Cell Nevus Syndrome/epidemiology , Patched-1 Receptor/analysis , Basal Cell Nevus Syndrome/pathology , Carcinoma, Basal Cell/therapy , Odontogenic Cysts/diagnostic imaging , Odontogenic Cysts/therapy , Radiography, Panoramic/methods
8.
Actas Dermosifiliogr (Engl Ed) ; 109(3): 207-217, 2018 Apr.
Article in English, Spanish | MEDLINE | ID: mdl-29373110

ABSTRACT

Gorlin syndrome is a rare autosomal dominant disease caused by mutations in the sonic hedgehog signaling pathway. Of particular importance is the PTCH1 gene. The disease is characterized by the development of multiple basal cell carcinomas at young ages. These tumors may present with other skin manifestations such as palmoplantar pits and with extracutaneous manifestations such as odontogenic keratocysts and medulloblastoma. Although the dermatologist may be key for recognizing clinical suspicion of the syndrome, a multidisciplinary team is usually necessary for diagnosis, treatment, and follow-up. Skin treatment may be complicated due to the large number of basal cell carcinomas and the extent of involvement. In recent years, new drugs that inhibit targets in the sonic hedgehog pathway have been developed. Although these agents appear promising options for patients with Gorlin syndrome, their efficacy is limited by adverse effects and the development of resistance.


Subject(s)
Basal Cell Nevus Syndrome , Skin Neoplasms , Basal Cell Nevus Syndrome/diagnosis , Basal Cell Nevus Syndrome/genetics , Basal Cell Nevus Syndrome/therapy , Humans , Skin Neoplasms/diagnosis , Skin Neoplasms/genetics , Skin Neoplasms/therapy
10.
Actas dermo-sifiliogr. (Ed. impr.) ; 108(2): 140-144, mar. 2017. tab, ilus
Article in English | IBECS | ID: ibc-160861

ABSTRACT

BACKGROUND: Treatment of nail psoriasis remains a challenging and often disappointing situation. OBJECTIVE: To compare the efficacy, adverse reactions and tolerability of treatment of nail psoriasis with PDL vs. Nd:YAG, in association with betametasona calcipotriol gel. METHODS: An open, prospective intrapatient left-to-right study was designed. The right hand of each patient received treatment with PDL and the left hand with Nd:YAG. Betamethasone calcipotriol gel was applied once a day during the first week after each laser session. A total of four sessions were administered. RESULTS: The clinical efficacy was evaluated according to the NAPSI score. All patients showed improvement in nail bed and nail matrix psoriasis. The global NAPSI mean declined in 15.46 (p < 0.000). There was neither statistical difference between the reduction in nail bed and matrix NAPSI nor in the treatment with PDL vs. Nd:YAG. The administration of Nd:YAG was more painful. No serious adverse effects were documented. Limitations. No random assignment and the small number of patients. CONCLUSIONS: PDL and Nd:YAG have proven to be an effective treatment for nail psoriasis with no serious adverse effect. No statistically significant difference was found between the two treatments


ANTECEDENTES: El tratamiento de la psoriasis ungueal es una situación de difícil manejo y a menudo decepcionante para el dermatólogo. OBJETIVO: Comparar la eficacia, las reacciones adversas y la tolerabilidad del tratamiento de la psoriasis ungueal con PDL vs. Nd: YAG en asociación con gel de betametasona calcipotriol. MÉTODOS: Estudio prospectivo abierto con control intrapaciente izquierda-derecha. La mano derecha de cada paciente recibió tratamiento con PDL y la mano izquierda con Nd: YAG. Se aplicó gel de betametasona calcipotriol una vez al día durante la primera semana después de cada sesión de láser en las 2 manos. Se administraron un total de 4 sesiones. RESULTADOS: La eficacia clínica se evaluó de acuerdo con la escala NAPSI. Todos los pacientes mostraron una mejoría en las lesiones del lecho y de la matriz ungueal. La media global del NAPSI disminuyó en 15,46 (p < 0,000). No hubo diferencia significativa entre la mejoría de las lesiones del lecho y la matriz ni en el tratamiento con el PDL vs. Nd: YAG. La administración de Nd: YAG fue más dolorosa. No se documentaron efectos adversos graves. Limitaciones. Falta de asignación aleatoria y muestra pequeña. CONCLUSIONES: PDL y Nd: YAG han demostrado ser tratamientos eficaces para la psoriasis ungueal sin documentarse efectos adversos graves. No se encontró diferencia estadística significativa entre los 2 tratamientos


Subject(s)
Humans , Male , Female , Psoriasis/complications , Psoriasis/drug therapy , Onycholysis/complications , Onycholysis/drug therapy , Onycholysis/pathology , Laser Therapy/instrumentation , Laser Therapy/methods , Laser Therapy , Betamethasone/therapeutic use , Methotrexate/therapeutic use , Prospective Studies , Lasers, Solid-State , Hyperkeratosis, Epidermolytic/complications , Hyperkeratosis, Epidermolytic/drug therapy , Acitretin/therapeutic use
11.
Actas Dermosifiliogr ; 108(2): 140-144, 2017 Mar.
Article in English, Spanish | MEDLINE | ID: mdl-28118926

ABSTRACT

BACKGROUND: Treatment of nail psoriasis remains a challenging and often disappointing situation. OBJECTIVE: To compare the efficacy, adverse reactions and tolerability of treatment of nail psoriasis with PDL vs. Nd:YAG, in association with betametasona calcipotriol gel. METHODS: An open, prospective intrapatient left-to-right study was designed. The right hand of each patient received treatment with PDL and the left hand with Nd:YAG. Betamethasone calcipotriol gel was applied once a day during the first week after each laser session. A total of four sessions were administered. RESULTS: The clinical efficacy was evaluated according to the NAPSI score. All patients showed improvement in nail bed and nail matrix psoriasis. The global NAPSI mean declined in 15.46 (p<0.000). There was neither statistical difference between the reduction in nail bed and matrix NAPSI nor in the treatment with PDL vs. Nd:YAG. The administration of Nd:YAG was more painful. No serious adverse effects were documented. LIMITATIONS: No random assignment and the small number of patients. CONCLUSIONS: PDL and Nd:YAG have proven to be an effective treatment for nail psoriasis with no serious adverse effect. No statistically significant difference was found between the two treatments.


Subject(s)
Betamethasone/therapeutic use , Calcitriol/analogs & derivatives , Lasers, Dye , Low-Level Light Therapy , Nail Diseases/therapy , Psoriasis/therapy , Adult , Aged , Betamethasone/administration & dosage , Calcitriol/administration & dosage , Calcitriol/therapeutic use , Combined Modality Therapy , Drug Combinations , Female , Gels , Humans , Lasers, Solid-State , Male , Middle Aged , Nail Diseases/drug therapy , Nail Diseases/radiotherapy , Prospective Studies , Psoriasis/drug therapy , Psoriasis/radiotherapy , Treatment Outcome
12.
Br J Dermatol ; 177(1): 168-178, 2017 Jul.
Article in English | MEDLINE | ID: mdl-27943259

ABSTRACT

BACKGROUND: Cutaneous squamous cell carcinoma (CSCC) is the second most widespread cancer in humans and its incidence is rising. These tumours can evolve as diseases of poor prognosis, and therefore it is important to identify new markers to better predict its clinical evolution. OBJECTIVES: We aimed to identify the expression pattern of microRNAs (miRNAs or miRs) at different stages of skin cancer progression in a panel of murine skin cancer cell lines. Owing to the increasing importance of miRNAs in the pathogenesis of cancer, we considered the possibility that miRNAs could help to define the prognosis of CSCC and aimed to evaluate the potential use of miR-203 and miR-205 as biomarkers of prognosis in human tumours. METHODS: Seventy-nine human primary CSCCs were collected at the University Hospital of Salamanca in Spain. We identified differential miRNA expression patterns at different stages of CSCC progression in a well-established panel of murine skin cancer cell lines, and then selected miR-205 and miR-203 to evaluate their association with the clinical prognosis and evolution of human CSCC. RESULTS: miR-205 was expressed in tumours with pathological features recognized as indicators of poor prognosis such as desmoplasia, perineural invasion and infiltrative growth pattern. miR-205 was mainly expressed in undifferentiated areas and in the invasion front, and was associated with both local recurrence and the development of general clinical events of poor evolution. miR-205 expression was an independent variable selected to predict events of poor clinical evolution using the multinomial logistic regression model described in this study. In contrast, miR-203 was mainly expressed in tumours exhibiting the characteristics associated with a good prognosis, was mainly present in well-differentiated zones, and rarely expressed in the invasion front. Therefore, the expression and associations of miR-205 and miR-203 were mostly mutually exclusive. Finally, using a logistic biplot we identified three clusters of patients with differential prognosis based on miR-203 and miR-205 expression, and pathological tumour features. CONCLUSIONS: miR-205 and miR-203 tended to exhibit mutually exclusive expression patterns in human CSCC. This work highlights the utility of miR-205 and miR-203 as prognostic markers in CSCC.


Subject(s)
Carcinoma, Squamous Cell/diagnosis , MicroRNAs/metabolism , Skin Neoplasms/diagnosis , Biomarkers/metabolism , Cell Line, Tumor , Cell Transformation, Neoplastic , Disease Progression , Humans , Neoplasm Grading , Prognosis
13.
Br J Dermatol ; 176(5): 1279-1287, 2017 May.
Article in English | MEDLINE | ID: mdl-27510450

ABSTRACT

BACKGROUND: Cutaneous squamous cell carcinoma (CSCC) is the second most frequent cancer in humans after basal cell carcinoma, and its incidence is dramatically rising. CSCC is rarely problematic, but given its high frequency, the absolute number of complicated cases is also high. It is necessary to identify molecular markers in order to recognize those CSCCs with poor prognosis. There is controversy concerning the role of epidermal growth factor receptor (EGFR) as a marker of prognosis in CSCC. In addition, EGFR-targeted therapies have emerged in recent years and a better understanding of the role of EGFR in CSCC may be of help for some patients in predicting prognosis and guiding curative management. OBJECTIVES: To evaluate the role of EGFR as a prognostic factor in CSCC. METHODS: We evaluated clinical and histopathological features, including events of poor clinical evolution, in a series of 94 cases of CSCC. We also analysed EGFR expression by immunohistochemistry, fluorescent in situ hybridization and quantitative polymerase chain reaction. RESULTS: We detected EGFR in 85 cases (90%), with overexpression in 33 cases (35%), and aberrant EGFR expression in the cytoplasm in 50 cases (53%). EGFR overexpression in the primary tumours was associated with lymph node progression, tumour-nodes-metastasis stage progression and proliferation (Ki-67 staining) in CSCC. EGFR overexpression and poor grade of differentiation were the strongest independent variables defining lymph node metastasis and progression in CSCC in a logistic regression model. CONCLUSIONS: We demonstrate that EGFR overexpression has prognostic implications associated with lymph node metastasis and progression in CSCC.


Subject(s)
Biomarkers, Tumor/metabolism , Carcinoma, Squamous Cell/diagnosis , ErbB Receptors/metabolism , Skin Neoplasms/diagnosis , Aged, 80 and over , Carcinoma, Squamous Cell/genetics , Disease Progression , ErbB Receptors/genetics , Female , Humans , Immunohistochemistry , Lymphatic Metastasis , Male , Prognosis , Risk Factors , Skin Neoplasms/genetics
14.
Actas dermo-sifiliogr. (Ed. impr.) ; 107(8): 666-673, oct. 2016. graf, tab
Article in Spanish | IBECS | ID: ibc-156391

ABSTRACT

INTRODUCCIÓN: La existencia de guardias de Dermatología es escasa en nuestro sistema nacional de salud. El objetivo del presente estudio es definir cuáles son los grupos de enfermedades y afecciones dermatológicas más frecuentes que acuden a urgencias y valorar la necesidad de dichas guardias para la formación del médico interno residente (MIR). MATERIAL Y MÉTODOS: Estudio descriptivo de los pacientes que acudieron a urgencias de Dermatología durante el periodo de un año (junio de 2013-mayo de 2014), que fueron evaluados por 9 MIR de la especialidad. Las variables a estudio fueron: fecha/día, sexo, edad, diagnóstico, procedimientos quirúrgicos especiales, pruebas complementarias de laboratorio, si requirieron o no hospitalización o revisión. Además, se evaluaron los pacientes nuevos que acudieron a una consulta programada de Dermatología entre los meses de enero y junio del 2014, con el objetivo de comparar las afecciones más frecuentes en ambos grupos. RESULTADOS: Un total de 3.084 pacientes fueron atendidos en urgencias dermatológicas, que representó el 5,6% de las urgencias vistas en el hospital. Se realizaron 152 diagnósticos diferentes. Los grupos de enfermedades más frecuentes fueron: infecciosas (23%) y eccemas (15,1%). Los diagnósticos individuales fueron: urticaria aguda (7,6%), eccema de contacto (6,1%) y toxicodermias (4,6%). Ello contrasta con los diagnósticos más frecuentes en los 1.288 pacientes estudiados pertenecientes a la consulta programada (queratosis seborreica [11,9%], nevus melanocítico [11,5%] y queratosis actínica [8%]). Un 42% de los pacientes vistos en urgencias requirió revisión; los MIR de 4º año fueron los que menor número de revisiones generaron. CONCLUSIONES: En nuestro estudio el grupo de dolencias infecciosas y eccemas representan cerca del 40% del total de las consultas urgentes. Nuestros resultados parecen indicar que la realización de guardias de Dermatología por parte de los MIR de esta especialidad es de gran utilidad para el sistema hospitalario y que son necesarias en la formación integral del especialista en Dermatología


BACKGROUND AND OBJECTIVE: Dermatology in-house call is uncommon in the Spanish national health system. The objective of the present study was to define the groups of dermatologic diseases and conditions most frequently seen in the emergency department and to evaluate the need for dermatology in-house call in the training of medical residents. MATERIAL AND METHODS: We performed a descriptive study of all patients who attended the emergency department with a skin complaint during a 1-year period (June 2013 to May 2014) and were assessed by 9 dermatology residents. The study variables were date/day, sex, age, diagnosis, special surgical procedures, additional laboratory tests, and need for hospitalization and/or follow-up. We also evaluated patients attending their first scheduled visit to the dermatologist between January and June 2014 in order to compare the most frequent conditions in both groups. RESULTS: A total of 3084 patients attended the emergency room with a skin complaint (5.6% of all visits to the emergency department), and 152 different diagnoses were made. The most frequent groups of diseases were infectious diseases (23%) and eczema (15.1%). The specific conditions seen were acute urticaria (7.6%), contact dermatitis (6.1%), and drug-induced reactions (4.6%). By contrast, the most frequent conditions seen in the 1288 patients who attended a scheduled dermatology appointment were seborrheic keratosis (11.9%), melanocytic nevus (11.5%), and actinic keratosis (8%). A follow-up visit was required in 42% of patients seen in the emergency department. Fourth-year residents generated the lowest number of follow-up visits. CONCLUSIONS: We found that infectious diseases and eczema accounted for almost 40% of all emergency dermatology visits. Our results seem to indicate that the system of in-house call for dermatology residents is very useful for the hospital system and an essential component of the dermatology resident's training program


Subject(s)
Humans , Male , Female , Emergencies/epidemiology , Internship and Residency , Tertiary Care Centers/statistics & numerical data , Skin Diseases/epidemiology , Dermatology/education , Skin Diseases/surgery , Skin Diseases, Infectious/epidemiology , Eczema/epidemiology , Postoperative Complications/epidemiology , Diagnosis-Related Groups , Spain/epidemiology , Retrospective Studies
15.
Actas Dermosifiliogr ; 107(8): 666-73, 2016 Oct.
Article in English, Spanish | MEDLINE | ID: mdl-27238743

ABSTRACT

BACKGROUND AND OBJECTIVE: Dermatology in-house call is uncommon in the Spanish national health system. The objective of the present study was to define the groups of dermatologic diseases and conditions most frequently seen in the emergency department and to evaluate the need for dermatology in-house call in the training of medical residents. MATERIAL AND METHODS: We performed a descriptive study of all patients who attended the emergency department with a skin complaint during a 1-year period (June 2013 to May 2014) and were assessed by 9 dermatology residents. The study variables were date/day, sex, age, diagnosis, special surgical procedures, additional laboratory tests, and need for hospitalization and/or follow-up. We also evaluated patients attending their first scheduled visit to the dermatologist between January and June 2014 in order to compare the most frequent conditions in both groups. RESULTS: A total of 3084 patients attended the emergency room with a skin complaint (5.6% of all visits to the emergency department), and 152 different diagnoses were made. The most frequent groups of diseases were infectious diseases (23%) and eczema (15.1%). The specific conditions seen were acute urticaria (7.6%), contact dermatitis (6.1%), and drug-induced reactions (4.6%). By contrast, the most frequent conditions seen in the 1288 patients who attended a scheduled dermatology appointment were seborrheic keratosis (11.9%), melanocytic nevus (11.5%), and actinic keratosis (8%). A follow-up visit was required in 42% of patients seen in the emergency department. Fourth-year residents generated the lowest number of follow-up visits. CONCLUSIONS: We found that infectious diseases and eczema accounted for almost 40% of all emergency dermatology visits. Our results seem to indicate that the system of in-house call for dermatology residents is very useful for the hospital system and an essential component of the dermatology resident's training program.


Subject(s)
Dermatology/education , Emergencies/epidemiology , Internship and Residency , Skin Diseases/epidemiology , Tertiary Care Centers/statistics & numerical data , Adolescent , Adult , Aged , Aged, 80 and over , Child , Child, Preschool , Diagnosis-Related Groups , Eczema/epidemiology , Female , Humans , Infant , Infant, Newborn , Male , Middle Aged , Postoperative Complications/epidemiology , Retrospective Studies , Skin Diseases/surgery , Skin Diseases, Infectious/epidemiology , Spain/epidemiology , Young Adult
17.
Neurobiol Dis ; 87: 39-49, 2016 Mar.
Article in English | MEDLINE | ID: mdl-26706597

ABSTRACT

Spinal cord injury (SCI) involves large-scale deafferentation of supraspinal structures in the somatosensory system, producing well-known long-term effects at the thalamo-cortical level. We recently showed that SCI provokes immediate changes in cortical spontaneous and evoked responses and here, we have performed a similar study to define the immediate changes produced in the thalamic ventro-postero-lateral nucleus (VPL) that are associated with the forepaw and hindpaw circuits. Extracellular electrophysiological recordings from the VPL reflected the spontaneous activity and the responses to peripheral electrical stimulation applied to the paws. Accordingly, the activity of the neuronal populations recorded at specific thalamic locations that correspond to the forepaw and hindpaw circuits was recorded under control conditions and immediately after thoracic SCI. The results demonstrate that peripheral inputs from both extremities overlap on neuronal populations in the somatosensory thalamus. In addition, they show that the responses of thalamic neurons to forepaw and hindpaw stimuli are increased immediately after SCI, in association with a specific decrease in spontaneous activity in the hindpaw locations. Finally, the increased thalamic responses after SCI have a state-dependent component in relation with cortical activity. Together, our results indicate that the thalamic changes occurring immediately after SCI could contribute to the cortical changes also detected immediately after such spinal lesions.


Subject(s)
Somatosensory Cortex/physiopathology , Spinal Cord Injuries/physiopathology , Ventral Thalamic Nuclei/physiopathology , Animals , Disease Models, Animal , Evoked Potentials, Somatosensory/physiology , Forelimb/physiopathology , Hindlimb/physiopathology , Male , Neurons/physiology , Physical Stimulation , Rats, Wistar
18.
Br J Dermatol ; 173(4): 1050-3, 2015 Oct.
Article in English | MEDLINE | ID: mdl-25965775

ABSTRACT

Cutaneous graft-versus-host disease (GVHD) is a frequent complication of allogeneic bone marrow transplant and haematopoietic cell transplantation, but it is rarely presented as a Wolf's isotopic response. We report a patient who developed chronic lichenoid GVHD following the dermatomes previously affected by varicella zoster virus (VZV) infection. Nineteen months later, the same patient suffered from reactivation of GVHD at the injection site of an influenza vaccination. We review the literature concerning GVHD appearing after VZV infection and discuss the possible implications of this case and the pathogenic hypotheses.


Subject(s)
Graft vs Host Disease/etiology , Herpes Zoster/complications , Influenza Vaccines/adverse effects , Lichenoid Eruptions/etiology , Bone Marrow Transplantation/adverse effects , Chronic Disease , Female , Hematopoietic Stem Cell Transplantation/adverse effects , Humans , Middle Aged , Myelodysplastic Syndromes/therapy , Recurrence , Transplantation, Homologous
19.
Pharmacogenomics J ; 15(4): 322-5, 2015 Aug.
Article in English | MEDLINE | ID: mdl-25403996

ABSTRACT

Psoriasis is a prevalent autoimmune disease of the skin that causes significant psychological and physical disability. Tumor necrosis factor (TNF)-blocking agents have proven to be highly efficacious in the management of moderate-to-severe psoriasis. However, a significant percentage of patients do not respond to this treatment. Recently, variation at the PDE3A-SLCO1C1 (phosphodiesterase 3A-SoLute Carrier Organic anion transporter family member 1C1) locus has been robustly associated with anti-TNF response in rheumatoid arthritis. Using a cohort of 130 psoriasis patients treated with anti-TNF therapy, we sought to analyze the association of this locus with treatment response in psoriasis. We found a highly significant association between PDE3A-SLCO1C1 and the clinical response to TNF blockers (P=0.0031). Importantly, the allele that was previously associated with the lack of response to rheumatoid arthritis (G allele, single-nucleotide polymorphism rs3794271) was associated with a higher anti-TNF efficacy in psoriasis. The results of this study are an important step in the characterization of the pharmacogenetic profile associated with anti-TNF response in psoriasis.


Subject(s)
Antirheumatic Agents/therapeutic use , Cyclic Nucleotide Phosphodiesterases, Type 3/genetics , Organic Anion Transporters/genetics , Psoriasis/drug therapy , Psoriasis/genetics , Tumor Necrosis Factor-alpha/antagonists & inhibitors , Adult , Alleles , Arthritis, Rheumatoid/drug therapy , Arthritis, Rheumatoid/genetics , Cohort Studies , Endpoint Determination , Female , Genetic Variation , Genotype , Humans , Male , Middle Aged , Polymorphism, Single Nucleotide , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...